TNFRSF4 Antikörper
TNFRSF4
Reaktivität: Ratte
FACS, IHC, IP
Wirt: Maus
Monoclonal
3H1849
unconjugated
Produktnummer ABIN2222643
-
-
Target
Alle TNFRSF4 Antikörper anzeigen
-
TNFRSF4
(Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
-
Reaktivität
-
Ratte
-
Wirt
-
Maus
-
Klonalität
-
Monoklonal
-
Konjugat
-
Dieser TNFRSF4 Antikörper ist unkonjugiert
-
Applikation
-
Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunoprecipitation (IP)
-
Kreuzreaktivität
-
Ratte (Rattus)
-
Kreuzreaktivität (Details)
-
Calculated cross reactivity: Rt
-
Produktmerkmale
-
CD134 (CD134 Antigen, ACT35, ACT35 Antigen, Lymphoid Activation Antigen ACT35, OX40, OX40 Cell Surface Antigen, OX40 Homolog, OX40L Receptor, RP5-902P8.3, TAX Transcriptionally-activated Glycoprotein 1 Receptor, Tumor Necrosis Factor Receptor Superfamily Member 4, TNFRSF4, Txgp1L)
-
Aufreinigung
-
Purified by Protein G affinity chromatography.
-
Immunogen
-
Phytohemagglutinin (PHA) activated Rat Lymph Node Cells.
-
Klon
-
3H1849
-
Isotyp
-
IgG2b
-
Top Product
-
Discover our top product TNFRSF4 Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working conditions should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Buffer
-
Supplied as a liquid in PBS, pH 7.4, 0.09 % sodium azide.
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
4 °C,-20 °C
-
Informationen zur Lagerung
-
4°C/-20°C (No Glycerol)
-
-
Target
-
TNFRSF4
(Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
-
Andere Bezeichnung
-
CD134 (TNFRSF4 Produkte)
-
Synonyme
-
TNFRSF4 antikoerper, ACT35 antikoerper, CD134 antikoerper, Ly-70 antikoerper, Ox40 antikoerper, TXGP1L antikoerper, Txgp1 antikoerper, OX40 antikoerper, TNF receptor superfamily member 4 antikoerper, tumor necrosis factor receptor superfamily, member 4 antikoerper, TNFRSF4 antikoerper, Tnfrsf4 antikoerper
-
Pathways
-
Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-